Mbd2 promotes foxp3 demethylation and T-regulatory-cell function

Molecular and Cellular Biology

Volumn 33, Issue 20, 2013, Pages 4106-4115

  Wang, Liqing ^a   Liu, Yujie ^a   Han, Rongxiang ^a   Beier, Ulf H ^b,c   Thomas, Rajan M ^a   Wells, Andrew D ^a,c   Hancock, Wayne W ^a,c  

^a Department of Pathology and Laboratory Medicine   (United States)

^b Division of Nephrology   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; OXYGENASE; PROTEIN TET2; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DEMETHYLATION; GENE EXPRESSION; HISTONE MODIFICATION; HOMOLOGOUS RECOMBINATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; METHYLATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY T LYMPHOCYTE;

ANIMALS; BINDING SITES; CD4 LYMPHOCYTE COUNT; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION TEST; LYMPH NODES; MICE; MICE, KNOCKOUT; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPLEEN; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TRANSCRIPTION, GENETIC;

EID: 84886875425     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00144-13     Document Type: Article

References (48)

1. Kass SU, Pruss D, Wolffe AP. 1997. How does DNA methylation repress transcription? Trends Genet. 13:444-449.
2. Defossez PA, Stancheva I. 2011. Biological functions of methyl-CpGbinding proteins. Prog. Mol. Biol. Transl. Sci. 101:377-398.
3. Dhasarathy A, Wade PA. 2008. The MBD protein family-reading an epigenetic mark? Mutat. Res. 647:39-43.
4. Bhattacharya SK, Ramchandani S, Cervoni N, Szyf M. 1999. A mammalian protein with specific demethylase activity for mCpG DNA. Nature 397:579-583.
5. Detich N, Theberge J, Szyf M. 2002. Promoter-specific activation and demethylation by MBD2/demethylase. J. Biol. Chem. 277:35791-35794.
6. Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Vilardell-Tarres M. 2007. Transcript overexpression of the MBD2 and MBD4 genes in CD4 T cells from systemic lupus erythematosus patients. J. Leukoc. Biol. 81:1609-1616.
7. Liu CC, Ou TT, Wu CC, Li RN, Lin YC, Lin CH, Tsai WC, Liu HW, Yen JH. 2011. Global DNA methylation, DNMT1, and MBD2 in patients with systemic lupus erythematosus. Lupus 20:131-136.
8. Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Zhou Y, Long H, Zhao M, Liang Y, Su Y, Lu Q. 2009. Abnormal DNA methylation in CD4 T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 38:369-374.
9. Liu CC, Fang TJ, Ou TT, Wu CC, Li RN, Lin YC, Lin CH, Tsai WC, Liu HW, Yen JH. 2011. Global DNA methylation, DNMT1, and MBD2 in patients with rheumatoid arthritis. Immunol. Lett. 135:96-99.
10. Zhang P, Su Y, Chen H, Zhao M, Lu Q. 2010. Abnormal DNA methylation in skin lesions and PBMCs of patients with psoriasis vulgaris. J. Dermatol. Sci. 60:40-42.
11. Vilain A, Vogt N, Dutrillaux B, Malfoy B. 1999. DNA methylation and chromosome instability in breast cancer cell lines. FEBS Lett. 460:231-234.
12. Ng HH, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument- Bromage H, Tempst P, Reinberg D, Bird A. 1999. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat. Genet. 23:58-61.
13. Boeke J, Ammerpohl O, Kegel S, Moehren U, Renkawitz R. 2000. The minimal repression domain of MBD2b overlaps with the methyl-CpGbinding domain and binds directly to Sin3A. J. Biol. Chem. 275:34963-34967.
14. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, Wolffe AP. 1999. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat. Genet. 23:62-66.
15. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. 2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930-935.
16. Zheng Y, Rudensky AY. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8:457-462.
17. Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27:68-73.
18. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27:20-21.
19. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J. 2007. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5:e38. doi:10.1371/journal.pbio.0050038.
20. Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY. 2010. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463:808-812.
21. Toker A, Engelbert D, Garg G, Polansky JK, Floess S, Miyao T, Baron U, Duber S, Geffers R, Giehr P, Schallenberg S, Kretschmer K, Olek S, Walter J, Weiss S, Hori S, Hamann A, Huehn J. 2013. Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J. Immunol. 190:3180-3188.
22. Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, Li B, Turka LA, Olson EN, Greene MI, Wells AD, Hancock WW. 2007. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13:1299-1307.
23. de Zoeten EF, Wang L, Butler K, Beier UH, Akimova T, Sai H, Bradner JE, Mazitschek R, Kozikowski AP, Matthias P, Hancock WW. 2011. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3 T-regulatory cells. Mol. Cell. Biol. 31:2066-2078.
24. de Zoeten EF, Wang L, Sai H, Dillmann WH, Hancock WW. 2010. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gastroenterology 138:583-594.
25. Beier UH, Wang L, Bhatti TR, Liu Y, Han R, Ge G, Hancock WW. 2011. Sirtuin-1 targeting promotes Foxp3 T-regulatory cell function and prolongs allograft survival. Mol. Cell. Biol. 31:1022-1029.
26. Sasai N, Defossez PA. 2009. Many paths to one goal? The proteins that recognize methylated DNA in eukaryotes. Int. J. Dev. Biol. 53:323-334.
27. Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A. 2001. Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev. 15:710-723.
28. Hancock WW, Sayegh MH, Zheng XG, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc. Natl. Acad. Sci. U. S. A. 93:13967-13972.
29. Wang L, Liu Y, Beier UH, Han R, Bhatti TR, Akimova T, Hancock WW. Foxp3 T-regulatory cells requireDNAmethyltransferase 1 expression to prevent development of lethal autoimmunity. Blood 121:3631-3639.
30. Thomas RM, Gao L, Wells AD. 2005. Signals from CD28 induce stable epigenetic modification of the IL-2 promoter. J. Immunol. 174:4639-4646.
31. Battke F, Symons S, Nieselt K. 2010. Mayday-integrative analytics for expression data. BMC Bioinformatics 11:121. doi:10.1186/1471-2105-11-121.
32. Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4:44-57.
33. Hutchins AS, Mullen AC, Lee HW, Sykes KJ, High FA, Hendrich BD, Bird AP, Reiner SL. 2002. Gene silencing quantitatively controls the function of a developmental trans-activator. Mol. Cell 10:81-91.
34. Lee I, Wang L, Wells AD, Dorf ME, Ozkaynak E, Hancock WW. 2005. Recruitment of Foxp3 T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201:1037-1044.
35. Chen C, Rowell EA, Thomas RM, Hancock WW, Wells AD. 2006. Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation. J. Biol. Chem. 281: 36828-36834.
36. Liu Y, Wang L, Han R, Beier UH, Hancock WW. 2012. Two lysines in the forkhead domain of foxp3 are key to T regulatory cell function. PLoS One 7:e29035. doi:10.1371/journal.pone.0029035.
37. Wang L, de Zoeten EF, Greene MI, Hancock WW. 2009. Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3 regulatory T cells. Nat. Rev. Drug Discov. 8:969-981.
38. Feng Q, Zhang Y. 2001. The MeCP1 complex represses transcription through preferential binding, remodeling, and deacetylating methylated nucleosomes. Genes Dev. 15:827-832.
39. Nishikawa H, Sakaguchi S. 2010. Regulatory T cells in tumor immunity. Int. J. Cancer 127:759-767.
40. Liu Y, Wang L, Predina J, Han R, Beier UH, Wang LCS, Kapoor V, Bhatti TR, Akimova T, Singhal S, Brindle PK, Cole PA, Albelda SM, Hancock WW. Inhibition of p300 impairs Foxp3 T-regulatory cell function and promotes anti-tumor immunity. Nat. Med., in press.
41. Ivanov MA, Lamrihi B, Szyf M, Scherman D, Bigey P. 2003. Enhanced antitumor activity of a combination of MBD2-antisense electrotransfer gene therapy and bleomycin electrochemotherapy. J. Gene Med. 5:893-899.
42. Campbell PM, Bovenzi V, Szyf M. 2004. Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivo. Carcinogenesis 25:499-507.
43. Sansom OJ, Berger J, Bishop SM, Hendrich B, Bird A, Clarke AR. 2003. Deficiency of Mbd2 suppresses intestinal tumorigenesis. Nat. Genet. 34: 145-147.
44. Carey N, Marques CJ, Reik W. 2011. DNA demethylases: a new epigenetic frontier in drug discovery. Drug Discov. Today 16:683-690.
45. Swaminathan V, Reddy BA, Ruthrotha Selvi B, Sukanya MS, KunduTK. 2007. Small molecule modulators in epigenetics: implications in gene expression and therapeutics. Subcell. Biochem. 41:397-428.
46. Ghoshal K, Majumder S, Datta J, Motiwala T, Bai S, Sharma SM, Frankel W, Jacob ST. 2004. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression. J. Biol. Chem. 279:6783-6793.
47. Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M. The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res. 31:1765-1774.
48. Sekimata M, Takahashi A, Murakami-Sekimata A, Homma Y. 2001. Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2. J. Biol. Chem. 276:42632-42638.